Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function

Acta Radiologica

Volumn 39, Issue 4, 1998, Pages 362-367

  Lundqvist, Stephan ^a   Holmberg, G ^a   Jakobsson, G ^a   Lithner, F ^a   Skinningsrud, K ^b   Stegmayr, B ^a   Hietala, S O ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b NYCOMED IMAGING AS   (Norway)

Author keywords

Diabetes mellitus; Iohexol, adverse events; Renal function, nephrotoxicity; Urography, contrast media

Indexed keywords

CONTRAST MEDIUM; IOHEXOL;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; FEMALE; HUMAN; KIDNEY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REFERENCE VALUE; STATISTICAL MODEL; TIME; URINE; UROGRAPHY;

ADULT; AGED; CONTRAST MEDIA; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; IOHEXOL; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES; TIME FACTORS; UROGRAPHY;

EID: 0032111071     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841859809172445     Document Type: Article

References (40)

1. ALMÉN T.: Experimental investigations with iohexol and their clinical relevance. In: Iohexol - Omnipaque. Clinical experience with a new non-ionic contrast medium, p. 17. Edited by E. Boijsen & T. Aakhus. Acta Radiol. Suppl. 366 (1983).
2. ALVING A. S. & MILLER B. F.: A practical method for the measurement of glomerular filtration rate (inulin clearance). Arch. Intern. Med. 66 (1940), 306.
3. BARRET B. J. & CARLISLE E.-J.: Meta-analysis of the relative nephrotoxicity of high and low osmolality iodinated contrast media. Radiology 188 (1993), 171.
4. BARRET B. J., PARFREY P. S., VAVASOUR H. M. et al.: Contrast nephropathy in patients with impaired renal function. High versus low osmolar media. Kidney Int. 41 (1992), 1274.
5. BERNS J. S. & RUDNICK M. R.: Radiocontrast media associated nephrotoxicity. Kidney 24 (1992), 1.
6. BERG K. J. & JAKOBSEN J.: Nephrotoxicity related to contrast media. In: Patient safety and adverse events in contrast medium examinations, p. 112. Edited by I. Enge & J. Edgren. Congress Series 816, Excerpta Medica, Amsterdam 1989.
7. BILLSTRÖM Å., HIETALA S.-O., LITHNER F., MERIKANTO J., WIRELL M. & WIRELL S.: Nephrotoxicity of contrast media in patients with diabetes mellitus. A comparative urographic and angiographic study with iohexol and metrizoate. Acta Radiol. 30 (1989), 509.
8. 51Cr-EDTA clearance. Acta Radiol. Diagn. 28 (1987), 581.
9. BROWN S. C. W. & O'REILLY P. H.: The estimate of glomerular filtration rate during urography. Acceptability of a nonionic contrast medium as a marker of renal function. Invest. Radiol. 27 (1992), 774.
10. DAHLSTRÖM K.: Summary of US and European intravascular experience with iohexol. Invest. Radiol. 20 (1985), 117.
11. DAWSON P. & TREWHELLA M.: Intravascular contrast agents and renal failure. Clin. Radiol. 41 (1990), 373.
12. DODGE W. F., TRAVIS L. D. & DAESCHNER C. W.: Comparison of endogenous creatinine clearance with inulin clearance. Am. J. Dis. Child. 113 (1967), 683.
13. 51Cr-EDTA clearance. Invest. Radiol. 25 (1990), 778.
14. EDELSON J., SHAW D. & PALACE G.: Pharmacokinetics of iohexol, a new nonionic radiocontrast agent in humans. J. Pharm. Sci. 73 (1984), 993.
15. EDGREN J., LAASONEN E., GROOP P.-H. & GROOP L.: Iohexol and metrizoate in urography of insulin dependent patients. Acta Radiol. Diagn. 27 (1986), 265.
16. EKELUND L.: Iohexol in urography. Survey and present state, p. 25. Acta Radiol. Suppl. 366 (1983).
17. FRENNBY B., STERNER G., ALMÉN T., HAGSTAM K.-E., HULTBERG B. & JACOBSSON L.: The use of iohexol clearance to determine GFR in patients with severe chronic renal failure - a comparison between different clearance techniques. Clin. Nephrol. 43 (1995), 35.
18. GOLMAN K., & ALMÉN T.: Contrast media induced nephrotoxicity. Survey and present state. Invest. Radiol. 20 (1985), 92.
19. HARRIS K. G., SMITH T. P., CRAGG A. H. & LEMKE J. H.: Nephrotoxicity from contrast material in renal insufficiency. Ionic versus nonionic aaents. Radiology 179 (1991), 849.
20. HIETALA S.-O. & ALMÉN T.: Patient risk factor of importance in nephrotoxicity of contrast media. In: Patient safety and adverse events in contrast medium examinations, p. 121. Edited by I. Enge & J. Edgren. Congress Series 816, Excerpta Medica, Amsterdam 1989.
21. HILL J. A., WINNIFORD M., COHEN M. D. et al.: Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. Am. J. Cardiol. 72 (1993), 770.
22. HOOD B., ATTMAN P. O., AHLMÉN J. & JAGENBURG R.: Renal haemodynamics and limitations of creatinine clearance in determining glomerular filtration rate in glomerular disease. Scand. J. Urol. Nephrol. 5 (1971), 154.
23. HUNTER J. V. & KIND P. R. N.: Nonionic iodinated contrast media. Potential renal damage assessed with enzymuria. Radiology 183 (1992), 101.
24. JAKOBSEN J., KOLBENSTVEDT A. N., LEVORSTAD K., BERG K. J. & ENGE I.: Renal effects of nonionic contrast media after intravenous, cardiac and lumbar aortic injections. Invest. Radiol. 25 (1990), 135.
25. JEUNIKAR A. M., FINNIE K. J. C., DENNIS B., PLUMMER D. F., AVILA A. & LINTON A. L.: Nephrotoxicity of high and low osmolality contrast media. Nephron 48 (1988), 300.
26. KRUTZÉN E., BÄCK S. E., NILSSON-EHLE I. & NILSSON-EHLE P.: Plasma clearance of a new contrast agent, iohexol. A method for the assessment of slomerular filtration rate. J. Clin. Med. 104 (1984), 955.
27. LAUTIN E. M., FREEMAN N. J., SCHOENFELD A. H. et al.: Radiocontrast-associated renal dysfunction. Incidence and risk factors. AJR 157 (1991), 49.
28. LAUTIN E. M., FREEMAN N. J., SCHOENFELD A. H. et al.: Radiocontrast-associated renal dysfunction. A comparison of lower osmolality and conventional high osmolality contrast media. AJR 157 (1991), 59.
29. LEVORSTAD K., VATNE K., BRODAHL U., LAAKE B., SIMONSEN S. & AAKHUS T.: Safety of nonionic contrast medium Omnipaque in coronary angiography. Cardiovasc. Intervent. Radiol. 12 (1989), 98.
30. 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation 48 (1989), 790.
31. MILLER B. F. & WINKLER A. W.: The renal excretion of endogenous creatinine in man. Comparison with endogenous creatinine and inulin. J. Clin. Invest. 17 (1938), 31.
32. MOORE R. D., STEINBERG E. P., POWE N. R. et al.: Nephrotoxicity of high-osmolality versus low-osmolality contrast media randomized clinical trial. Radiology 182 (1992), 649.
33. OLSSON B., AULIE Å., SVEEN K. & ANDREW E.: Human pharmacokinetics of iohexol. A non-ionic contrast medium. Invest. Radiol. 18 (1983), 177.
34. PARFREY P. S., GRIFFITHS S. M., BARRET B. J. et al.: Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. New Engl. J. Med. 320 (1989), 143.
35. SCHROTT K. M., BEHRENDS B., CLAUSS W., KAUFMANN J. & LEHNERT J.: Iohexol in excretory urography. Results of the drug monitoring programme. Fortschr. Med. 104 (1986), 153.
36. SHEMESH O., GOLBETZ H., KRISS J. & MYERS B.: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 28 (1985), 830.
37. STEGMAYR B., BJÖRCK L.-M., KEMPI V. & SEMB H.: Renal function not impaired by hip arthroplasty. A prospective study of 30 patients. Acta Orthop. Scand. 63 (1992), 7.
38. THOMSEN H. S.: Contrast nephropathy. Current Opin. Radiol. 2 (1990), 793.
39. THOMSEN H. S. & HVID-JACOBSEN K.: Estimation of glomerular filtration rate from low-dose injection of iohexol and a single blood sample. Invest. Radiol. 26 (1991), 332.
40. VAN LENTE F. & SUIT P.: Assessment of renal function by serum creatinine and creatinine clearance. Glomerular filtration rate estimated by four procedures. Clin. Chem. 35 (1989), 2326.